Regeneron Pharmaceuticals announced on Aug. 13, 2019 that FDA approved Eylea (aflibercept) Injection prefilled syringe for treating four retinal conditions. The drug is expected to be available to physicians and patients this year.
In the United States, Eylea is indicated to treat neovascuOriginal Article
